In a research note, Barclays analyst Emily Field has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 105.
The Ohio Supreme Court on Tuesday will become only the second state high court to hear oral arguments on whether the opioid epidemic is a public nuisance, the controversial legal theory underpinning numerous suits across the country including a $650 million award that two Ohio counties won against Walmart, CVS and Walgreens.